Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment-Reference-Cited by-同舟云学术

Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment

Published:2016-12 Issue:51 Volume:34 Page:6597-6609
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Clarke David K.,Hendry R. Michael,Singh Vidisha,Rose John K.,Seligman Stephen J.,Klug Bettina,Kochhar Sonali,Mac Lisa Marie,Carbery Baevin,Chen Robert T.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference93 articles.

1. Use of viral vectors for the development of vaccines;Liniger;Expert Rev Vacc,2007

2. Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference;Excler;Biologicals: J Int Assoc Biol Stand,2010

3. Viral vectors in malaria vaccine development;Limbach;Parasite Immunol,2009

4. Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization;Xing;Tuberculosis,2006

5. Applications and challenges of multivalent recombinant vaccines;Naim;Human Vacc Immunother,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus;Vaccines;2024-07-30

2. Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques;Viruses;2024-07-24

3. Translational success of fundamental virology: a VSV-vectored Ebola vaccine;Journal of Virology;2024-03-19

4. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases;Signal Transduction and Targeted Therapy;2023-04-07

5. Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T cells against SARS-CoV-2 variants;iScience;2023-04